| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |